日本市场个股详情

4516 日本新药

添加自选

4040.0
-32.0-0.79%

延时20分钟行情交易中 03/21 13:37 (东京)

2838.16亿总市值10.53市盈率(静)

关于日本新药公司

日本新药株式会社是一家专业和仿制药生产公司。日本的研发活动包括重点研究药品、营养品、药物种子的安全性和药代动力学、基因组药物发现和核酸药物。该公司还开发健康食品原料、防腐剂、蛋白质制剂和香料。日本将并购投资视为其扩大研究、开发、制造和营销能力的运营增长战略的潜在组成部分。

公司介绍

公司代码4516

公司名称日本新药

成立日期1919-10-01

所属市场东证Prime

员工数量2265

年结日03-31

公司地址14, Nishinosho-Monguchi-cho Kisshoin, Minami-ku

邮编601-8550

电话075-321-1111

网址www.nippon-shinyaku.co.jp

董事高管

姓名
职务
年薪

Takashi Takaya
Director and General Manager, Personnel, General Affairs, Risk Management, Compliance and Digital Transformation
--

Takanori Edamitsu
Director and General Manager, Business Management and Sustainability
--

Shouzou Sano
Director, Managing Director, General Manager, Sales and Marketing and Head of Sales and Marketing Division
--

Hitoshi Ishizawa
Director, General Manager, Functional Food and Head of Functional Food Division
--

Hitomi Kimura
Director and General Manager, Resource Procurement, Production and Assurance
--

Kazuchika Takagaki
Director, General Manager, Research and Development and Head of Research and Development Division
--

Shigenobu Maekawa
Chairman of the Board
--

Toru Nakai
Director and President
--

Miyuki Sakurai
Independent Director
--

Dr. Mayumi Nishi
Independent Director
--

Yukari Kobayashi
Independent Director
--

Dr. Yoshinao Wada, PhD
Independent Director
--